Literature DB >> 15910623

Nephropathy, but not retinopathy, is associated with the development of heart disease in Type 1 diabetes: a 12-year observation study of 462 patients.

O Torffvit1, M Lövestam-Adrian, E Agardh, C-D Agardh.   

Abstract

AIMS: To study the occurrence of heart disease and death in Type 1 diabetic patients and evaluate whether presence of microangiopathy, i.e. nephropathy and retinopathy, was associated with the outcome.
METHODS: A 12-year observation study of 462 Type 1 diabetic patients without a previous history of heart disease at baseline who were treated under routine care in a hospital out-patient clinic.
RESULTS: A total of 85 patients developed signs of heart disease, i.e. myocardial infarction (n = 41), angina (n = 23), and heart failure (n = 17) and 56 patients died. The mortality for patients without signs of heart disease during the observation period was 7.6% compared with 51% in patients with myocardial infarction (P < 0.001), 26% in patients with angina (P < 0.01) and 65% in patients with heart failure (P < 0.001). The relative risk for death was 9.0 (P < 0.001) and 2.5 (P < 0.05) times higher in patients with macroalbuminuria and microalbuminuria, respectively. The risk for cardiovascular death was 18.3 times (P < 0.001) higher in patients with macroalbuminuria compared with patients with normoalbuminuria. In patients with sight-threatening retinopathy, the relative risk for death was 7.0 times higher (P < 0.01) and the risk for coronary heart disease events 4.4 times higher (P < 0.05) compared with patients with no retinopathy. However, when retinopathy was adjusted for presence of macroalbuminuria, this association disappeared.
CONCLUSION: This study shows a high incidence of heart disease in patients with Type 1 diabetes. The worse prognosis was seen in patients with sight-threatening retinopathy and macroalbuminuria and microalbuminuria at baseline. Macroalbuminuria and microalbuminuria were independently associated with a high risk for heart disease and death while the association with sight-threatening retinopathy only occurred in the presence of nephropathy.

Entities:  

Mesh:

Year:  2005        PMID: 15910623     DOI: 10.1111/j.1464-5491.2005.01476.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  24 in total

Review 1.  Haptoglobin genotype and its role in diabetic cardiovascular disease.

Authors:  Tina Costacou; Andrew P Levy
Journal:  J Cardiovasc Transl Res       Date:  2012-03-24       Impact factor: 4.132

2.  Lipoprotein-associated phospholipase A2, C-reactive protein, and coronary artery disease in individuals with type 1 diabetes and macroalbuminuria.

Authors:  Rachel G Miller; Tina Costacou; Trevor J Orchard
Journal:  Diab Vasc Dis Res       Date:  2009-10-28       Impact factor: 3.291

3.  Augmentation pressure and subendocardial viability ratio are associated with microalbuminuria and with poor renal function in type 1 diabetes.

Authors:  Catherine T Prince; Aaron M Secrest; Rachel H Mackey; Vincent C Arena; Lawrence A Kingsley; Trevor J Orchard
Journal:  Diab Vasc Dis Res       Date:  2010-07-06       Impact factor: 3.291

4.  Risk stratification for 25-year cardiovascular disease incidence in type 1 diabetes: Tree-structured survival analysis of the Pittsburgh Epidemiology of Diabetes Complications study.

Authors:  Rachel G Miller; Stewart J Anderson; Tina Costacou; Akira Sekikawa; Trevor J Orchard
Journal:  Diab Vasc Dis Res       Date:  2016-04-21       Impact factor: 3.291

5.  The Association of Severe Diabetic Retinopathy With Cardiovascular Outcomes in Long-standing Type 1 Diabetes: A Longitudinal Follow-up.

Authors:  Drazenka Pongrac Barlovic; Valma Harjutsalo; Daniel Gordin; Milla Kallio; Carol Forsblom; George King; Per-Henrik Groop
Journal:  Diabetes Care       Date:  2018-09-26       Impact factor: 19.112

Review 6.  Challenges and Opportunities in the Management of Cardiovascular Risk Factors in Youth With Type 1 Diabetes: Lifestyle and Beyond.

Authors:  Michelle Katz; Elisa Giani; Lori Laffel
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

Review 7.  Angiotensin blockade to reduce microvascular damage in diabetes mellitus.

Authors:  Roland E Schmieder; Stephan Martin; Gabriele E Lang; Peter Bramlage; Michael Böhm
Journal:  Dtsch Arztebl Int       Date:  2009-08-24       Impact factor: 5.594

Review 8.  Prevalence and significance of cardiometabolic risk factors in children with type 1 diabetes.

Authors:  Sowmya Krishnan; Kevin R Short
Journal:  J Cardiometab Syndr       Date:  2009

Review 9.  Diabetic cardiomyopathy: pathophysiology and clinical features.

Authors:  Takayuki Miki; Satoshi Yuda; Hidemichi Kouzu; Tetsuji Miura
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

10.  Increased urine IgM excretion predicts cardiovascular events in patients with type 1 diabetes nephropathy.

Authors:  Rafid Tofik; Ole Torffvit; Bengt Rippe; Omran Bakoush
Journal:  BMC Med       Date:  2009-08-04       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.